Chengdu Easton Bio Pharmaceuticals Co., Ltd. logo

Chengdu Easton Bio Pharmaceuticals Co., Ltd. (688513)

Market Closed
11 Aug, 06:57
SSE SSE
¥
50. 11
+2.11
+4.3958%
¥
5.48B Market Cap
- P/E Ratio
2.32% Div Yield
4.36M Volume
- Eps
¥ 48
Previous Close
Add Transaction
Day Range
47.3 52.12
Year Range
40.25 80.48
Want to track 688513 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Chengdu Easton Bio Pharmaceuticals Co., Ltd. (688513) Statistics

Valuation metrics

Market Cap 5.48B
Enterprise value 8.58B
Trailing P/E (ttm) 31.53
Forward P/E -
PEG ratio 1.29
Price/Sales (ttm) 6.5
Price/Book (mrq) 2.91
Enterprise Value/Revenue 6.35
Enterprise Value/EBITDA 25.97

Overview

Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 2.73M
Average volume (90 days) 2.8M

Price summary

52-Week low 40.25
52-Week high 80.48
Beta -
50-Day moving average 50.08
200-Day moving average 57.36

Dividends and splits

Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate 0.49
Trailing annual dividend yield 0.0098%
5-Year annual dividend yield -
Payout ratio 0.28
Dividend Date 2 Jun 2026
Ex-Dividend Date 2 Jun 2026
Last split factor 1:1
Last split Date 1 Jul 2024

Financials

Fiscal year

Fiscal year ends -
Most recent quarter (mrq) -

Profitability

Profit margin 0.2%
Operating margin 0.21%

Operational effectiveness

Return on assets 0.07%
Return on equity 0.09%

Income Statement

Revenue (ttm) -
Revenue per share (ttm) 7.75
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) 1.57
Quarterly earnings growth (yoy) -

Balance Sheet

Total cash (mrq) -
Total cash per share (mrq) 9.3
Total debt (mrq) -
Total Debt/Equity (mrq) 0.04
Current ratio (mrq) 3.82%
Book value per share (mrq) 17.7

Cash Flow

Cash flow statement -
Levered free cash flow (LFCF) -